Lumefantrine and Belumosudil: Interaction Details
AI-assisted, pharmacist-reviewed · AI content regenerated Jul 15, 2026 · Source data updated Jul 11, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Lumefantrine
No brand names on recordBelumosudil
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
You've been prescribed belumosudil (Rezurock) along with artemether/lumefantrine, a malaria medicine. Belumosudil can slow down the liver enzyme (called CYP3A4) that normally breaks down the malaria drug. When that happens, the malaria medicine can build up a bit higher in your body.
The main thing to keep an eye on is a heart rhythm change called QT prolongation, which the malaria drug can cause on its own and which higher levels may make more likely. The good news: this concern is theoretical, and your care team can manage it easily by watching you a little more closely. Keep taking both exactly as prescribed and mention any dizziness, fainting, or palpitations to your pharmacist or doctor.
Mechanism: Belumosudil inhibits CYP3A4, the enzyme responsible for artemether/lumefantrine metabolism. Neither agent is relevant as a prodrug here, so reduced clearance is expected to increase artemether/lumefantrine exposure (AUC/Cmax).
Consequence: Additive/potentiated QT prolongation, as artemether/lumefantrine already carries QT liability.
- Evidence: theoretical
- Onset: unspecified
- Severity: moderate
Management: Use caution with coadministration. Consider baseline and follow-up ECG monitoring, correct electrolytes (K+, Mg2+), and review other QT-prolonging agents. Watch for palpitations, syncope, or dizziness.
What happens
Increased artemether/lumefantrine exposure and an increased risk of potentiated QT prolongation
Interaction Deep Dive
Use care when combining artemether/lumefantrine with CYP3A4 inhibitors, since such coadministration can raise artemether/lumefantrine exposure and heighten the risk of QT prolongation1.
Why it happens (mechanism)
Inhibition of CYP3A4-mediated metabolism of artemether/lumefantrine
How to manage this interaction
Your care team can manage this safely. Because belumosudil may raise levels of the malaria medicine and both can affect heart rhythm, they may:
- Monitor your heart more closely, sometimes with an ECG
- Check and correct electrolytes like potassium and magnesium
- Review your other medicines for any that also affect QT
What you should do: Keep taking both exactly as prescribed unless told otherwise. Let your pharmacist or prescriber know if you feel dizzy, faint, or notice a fluttering or pounding heartbeat, and confirm they are aware you are taking both drugs.
Management is individual — confirm any change with your pharmacist or prescriber.
Common questions
Can I take Lumefantrine and Belumosudil together?
Belumosudil may raise artemether/lumefantrine levels and add to the risk of QT prolongation, so your care team may monitor your heart and electrolytes more closely. Keep taking both as prescribed and report any dizziness, fainting, or palpitations. Always confirm with your pharmacist or prescriber before making any change.
How serious is the Lumefantrine and Belumosudil interaction?
It is rated moderate. Can be significant — usually manageable with monitoring.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How is the Lumefantrine and Belumosudil interaction managed?
Your care team can manage this safely. Because belumosudil may raise levels of the malaria medicine and both can affect heart rhythm, they may: Monitor your heart more closely, sometimes with an ECG Check and correct electrolytes like potassium and magnesium Review your other medicines for any that also affect QT What you should do: Keep taking both exactly as prescribed unless told otherwise. Let… Management is individual — always follow your own care team's guidance.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.
Questions for your pharmacist
- Does my dose of Lumefantrine or Belumosudil need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there anything you'd monitor while I'm on both?
References (1)
- Product Information: COARTEM® oral tablets, artemether lumefantrine oral tablets. Novartis Pharmaceuticals Corporation (per DailyMed), East Hanover, NJ, 2025. DailyMed
Keep reading about Lumefantrine
Keep reading about Belumosudil
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist